Herbas VPB

Spausdinti
EN | LT
LT - ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
EN - ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. A61K 31/517 (2006.01)
A61K 31/404 (2013.01)
A61K 31/416 (2006.01)
A61K 45/06 (2013.01)
A61K 31/404 (2006.01)
A61K 31/337 (2013.01)
A61K 31/136 (2006.01)
A61K 31/7048 (2013.01)
A61K 31/66 (2006.01)
A61K 31/7068 (2013.01)
A61K 31/198 (2006.01)
A61P 35/00 (2018.01)
A61P 35/00 (2006.01)
A61K 31/4439 (2013.01)
Europos patentas
(11) Patento numeris 3217983
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 15859462.2
Europos patento paraiškos padavimo data 2015-11-12
(97) Europos patento paraiškos paskelbimo data 2017-09-20
(45) Paskelbimo apie Europos patento išdavimą data 2024-05-01
(46) Apibrėžties vertimo paskelbimo data
Tarptautinės paraiškos padavimo
(86) Numeris PCT/US2015/060486
Data 2015-11-12
Tarptautinės paraiškos paskelbimo
(87) Numeris WO 2016/077652
Data 2016-05-19
Prioriteto paraiškos
(30) Numeris Data Šalis
201462078280 P 2014-11-11 US
Išradėjai
(72)
KOLESNICK, Richard , US
HAIMOVITZ-FRIEDMAN, Adriana , US
SALA, Evis , US
FUKS, Zvi , US
Savininkas
(73) Memorial Sloan Kettering Cancer Center , 1275 York Avenue, New York, NY 10021, US
Pavadinimas
(54) ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
  ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT